Now I have all the verification I need. Let me compose the final consolidated review.

## Summary

This paper applies transfer learning with ResNet-50 and EfficientNetV2 to four binary classification tasks (Cyst vs Normal, Cyst vs Stone, Cyst vs Tumor, Stone vs Tumor) using CT kidney images from a Kaggle dataset. Both models achieve near-perfect or perfect test accuracy, with EfficientNetV2 showing a marginal advantage. The paper's core contribution is the task decomposition into pairwise comparisons and the application of these architectures to this specific dataset.

## Strengths

- **Clear binary task decomposition**: The paper subdivides renal disease classification into four clinically meaningful pairwise comparisons (Cyst vs Normal, Cyst vs Stone, Cyst vs Tumor, Stone vs Tumor), which enables more focused diagnostic analysis than a single multiclass formulation. This design choice is explicitly justified.

- **Head-to-head architecture comparison**: The paper evaluates both ResNet-50 and EfficientNetV2 under the same experimental conditions, providing a direct comparison that shows EfficientNetV2's marginal advantage (perfect classification on Cyst vs Tumor where ResNet-50 had minor misclassifications) and faster training.

- **Complementary evaluation with ROC/AUC**: Figure 7 provides ROC curves and AUC values close to 1 for both models, offering a threshold-independent metric that complements the accuracy figures. The checkpoint mechanism for saving best weights based on validation accuracy is a reasonable practice.

- **Detailed discussion of initialization methods**: Sections 3.2 provides a thorough explanation of Xavier and He initialization, demonstrating awareness of best practices in deep learning training.

## Weaknesses

### Major

- **No verification of patient-level data splitting**: The paper does not establish whether the train/validation/test split was performed at the patient level. The dataset contains multiple CT slices ("axial cuts and coronal") that could originate from the same patient. If images from the same patient appear across splits, the 100% test accuracy is uninterpretable as a measure of generalization — this is a known failure mode in medical imaging. The paper does not mention deduplication, patient-level splitting, or even how many patients are in the dataset. Given that the paper reports perfect accuracy across all four tasks — an outcome that is extremely unusual even with transfer learning — this omission is the single most consequential gap.

- **Missing critical training details necessary for reproducibility**: The paper reports only "10 epochs with 256 iterations per epoch" but does not specify the optimizer (SGD? Adam?), learning rate (fixed? scheduled?), batch size, weight decay, or any data augmentation strategy. Without these details, the experiments cannot be reproduced or evaluated for soundness. Data augmentation is standard practice for small medical imaging datasets and its absence is particularly concerning for the smallest binary split (Stone vs Tumor, 3360 images).

- **No error analysis or disaggregated performance metrics**: The paper mentions "minor misclassifications" for ResNet-50 on Cyst vs Tumor but provides no confusion matrices, class-specific precision/recall, or analysis of which cases are misclassified. No class distribution is reported for the individual training/validation/test splits of each binary task. If classes are imbalanced, 100% accuracy could simply reflect majority-class prediction at a particular threshold — but this cannot be assessed from the reported aggregate metrics. The paper also reports no confidence intervals or variance estimates (e.g., across multiple random seeds or splits), so there is no way to judge the stability of the reported near-perfect scores.

### Minor

- **Abstract overclaims scope**: The abstract states the framework analyzes "CT scans and microscopic histopathology images," but the paper exclusively uses CT scans from the Kaggle CT KIDNEY DATASET. No histopathology data is used anywhere in the study. This is a factual error in the abstract that should be corrected.

- **Section organization is confusing**: Section 3 is titled "RESULT AND DISCUSSION" but contains methodology subsections (3.1 Dataset Overview, 3.2 Initialization of Weights, 3.3 Training Result and DL Models), making it difficult to separate experimental design from findings.

- **Vague efficiency claims**: The paper states that "Training with EfficientNetV2 was approximately faster than ResNet-50" but provides no wall-clock times, parameter counts, or FLOPs comparisons to support this claim. The statement that "progressive learning was not implemented here" about EfficientNetV2 is left as a dangling observation without explaining what was used instead.

### Trivial

- No random seed is reported, making the results not bit-exact reproducible (though this is secondary to the missing training details above).

## Nice-to-Haves

- 5-fold cross-validation with patient-level folds would provide stronger evidence than a single split. At minimum, reporting variance across multiple random splits would be informative.
- An ethics/IRB statement about the Kaggle dataset's collection and use, while not required for public data, would be appropriate given the paper's clinical framing.
- Data augmentation strategies (rotation, flipping, scaling) would help address the small-dataset concern and potentially strengthen generalization.
- Reporting the specific TensorFlow version and hardware used would aid reproducibility.

## Removed Points

These points are flagged to be removed; treat them with caution:

- **Criticism about the dataset summary table "not shown in the extracted text"**: The table exists as an image in the original paper (line 27). Its absence from the extracted text is a parser artifact, not an author error. *Removed per Hard Rule (parser artifacts).*
- **"Cannot be independently verified" phrasing about the dataset**: The dataset is a cited Kaggle resource (Kid, 2022). Doubting its existence or release status is not permitted per Hard Rules. The substantive concern (missing reproducibility details) is retained in the Major section. *Removed per Hard Rule (existence of cited entities).*
- **Complaint that novelty is "limited" / "work does not introduce any new method"**: This is an application/benchmark paper, and evaluating it against the expectation of a novel method is a category mismatch. The binary task decomposition is a legitimate contribution for this paper class. *Removed per Soft Rule (wrong class expectations).*
- **Request for IRB/prospective clinical trials as a weakness**: These are beyond what is expected for a conference submission using a public dataset. Moved to Nice-to-Haves. *Downgraded per Soft Rule (impractical asks for academic submission).*

## Novel Insights

None beyond the paper's own contributions. The reviews surface the tension between the paper's extraordinary reported results (100% accuracy across four binary tasks) and its ordinary experimental validation (single split, no patient-level separation, no augmentation, minimal training details). This mismatch is the central weakness that any revision must address. The binary task framing is a reasonable design choice, but it is devalued by the lack of rigorous validation.

## Suggestions

1. **Verify and report patient-level splitting**: Explicitly state whether the Kaggle dataset's splits respect patient identity. If not, re-split the data ensuring all images from each patient are confined to a single fold. Report the number of unique patients per split.
2. **Report all training hyperparameters**: Add optimizer (type, learning rate, schedule), batch size, weight decay, and any data augmentation used. If no augmentation was used, justify or add standard augmentations.
3. **Provide confusion matrices and class-specific metrics**: For each of the four binary tasks, report the test-set confusion matrix, class-specific precision/recall/F1, and the class distribution in each split.
4. **Add variance estimation**: Report accuracy across multiple random seeds or, ideally, multiple train/test splits with confidence intervals (e.g., bootstrapped 95% CI around accuracy).
5. **Fix the abstract**: Remove the reference to "microscopic histopathology images" or add such data to the study.
6. **Restructure Section 3**: Separate methodology (dataset, preprocessing, training setup) from results and discussion into clearly distinct sections.

## Score and Decision

The paper addresses a relevant clinical need and its binary task decomposition is a reasonable design choice. However, the experimental validation has fundamental gaps that undermine the credibility of the central claim (100% test accuracy): no evidence of patient-level splitting (critical for medical imaging), no training hyperparameters reported, no error analysis, and no statistical uncertainty quantification. The abstract contains a factual error about the data modality used. These issues are addressable in a major revision, but in its current form the paper does not provide sufficient evidence to support its conclusions.

**MY FINAL SCORE: <pineapple>3.0</pineapple>**
**MY FINAL DECISION: <orange>Reject</orange>**